Mayne Pharma reported $-63702000 in Operating Profit for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Ansell ANN:AU $ 113.7M 71.5M
Cochlear COH:AU $ 234.4M 103.7M
CSL CSL:AU $ 2.21B 1.44B
Ecofibre Ltd EOF:AU -8958000 7.11M
Healius Ltd HLS:AU $ 361.7M 248.2M
Integral Diagnostics Ltd IDX:AU 20.22M 633K
Nanosonics Ltd NAN:AU $ 3.35M 7.41M
Next Science Ltd NXS:AU -5210130 944.2K
Polynovo Ltd PNV:AU -2322660 416.32K
Probiotec Ltd PBP:AU 6.28M 711.35K
Ramsay Health Care RHC:AU $ 470.4M 103.3M
ResMed RMD:AU $ 234.26M 14.45M
Sigma Healthcare Ltd SIG:AU -2060000 6.43M
Sonic Healthcare SHL:AU $ 1.21B 283.02M
Telix Pharmaceuticals Ltd TLX:AU -45304000 15.36M